Less than three weeks after halting drug makers Mylan Inc. and Par Sterile Products from selling generic versions of Hospira Inc.’s blockbuster sedative Precedex, a judge in Baltimore performed an unexpected about-face on Friday that allows the generics to resume sales.
The decision by U.S. District Court Judge George Jarrod Hazel prompted an immediate appeal by Hospira and its lawyers at Venable, led by Paul Strain and Ralph Tyler. Hospira also filed an emergency motion for an injunction pending the outcome of its appeal, but on Monday the U.S. Court of Appeals for the Fourth Circuit denied the request.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
